5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide

C29H26N8O5 — CID 143346351

IUPAC5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide
SMILESC=CCOCC(=O)c1ccc2c(c1C)CC[C@@H]2NC(=O)c1cc(C(=O)NCc2ccc3nonc3c2)nc2ncnn12
InChIInChI=1S/C29H26N8O5/c1-3-10-41-14-26(38)19-5-6-20-18(16(19)2)7-9-21(20)33-28(40)25-12-24(34-29-31-15-32-37(25)29)27(39)30-13-17-4-8-22-23(11-17)36-42-35-22/h3-6,8,11-12,15,21H,1,7,9-10,13-14H2,2H3,(H,30,39)(H,33,40)/t21-/m0/s1
InChIKeyCVNCROJHHXJXAV-NRFANRHFSA-N
MW566.58 g/mol
LogP2.70
Rot. Bonds10

About 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide

5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide (PubChem CID 143346351) has the molecular formula C29H26N8O5 and a molecular weight of 566.58 g/mol. Its IUPAC name is 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide.

Molecular Properties

Compound Name5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide
PubChem CID143346351
Molecular FormulaC29H26N8O5
Molecular Weight566.58 g/mol
Exact Mass566.20
IUPAC Name5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide
SMILESC=CCOCC(=O)c1ccc2c(c1C)CC[C@@H]2NC(=O)c1cc(C(=O)NCc2ccc3nonc3c2)nc2ncnn12
InChIInChI=1S/C29H26N8O5/c1-3-10-41-14-26(38)19-5-6-20-18(16(19)2)7-9-21(20)33-28(40)25-12-24(34-29-31-15-32-37(25)29)27(39)30-13-17-4-8-22-23(11-17)36-42-35-22/h3-6,8,11-12,15,21H,1,7,9-10,13-14H2,2H3,(H,30,39)(H,33,40)/t21-/m0/s1
InChIKeyCVNCROJHHXJXAV-NRFANRHFSA-N
XLogP2.70
TPSA166.50 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds10
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500566.58
LogP ≤ 52.70
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide?
The IUPAC name of 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide (CID 143346351) is 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide.
What is the SMILES notation for 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide?
The canonical SMILES for 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide is C=CCOCC(=O)c1ccc2c(c1C)CC[C@@H]2NC(=O)c1cc(C(=O)NCc2ccc3nonc3c2)nc2ncnn12.
What is the InChIKey of 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide?
The InChIKey is CVNCROJHHXJXAV-NRFANRHFSA-N. The full InChI is InChI=1S/C29H26N8O5/c1-3-10-41-14-26(38)19-5-6-20-18(16(19)2)7-9-21(20)33-28(40)25-12-24(34-29-31-15-32-37(25)29)27(39)30-13-17-4-8-22-23(11-17)36-42-35-22/h3-6,8,11-12,15,21H,1,7,9-10,13-14H2,2H3,(H,30,39)(H,33,40)/t21-/m0/s1.
What are the key properties of 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide?
5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide has a molecular weight of 566.58 g/mol, XLogP of 2.70, 10 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 5-N-(2,1,3-benzoxadiazol-5-ylmethyl)-7-N-[(1S)-4-methyl-5-(2-prop-2-enoxyacetyl)-2,3-dihydro-1H-inden-1-yl]-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-dicarboxamide is sourced from PubChem (CID 143346351), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).